Logo

Biosearch Strikes License Pact with Roche

Oct 01, 2009

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed a family of patents from Roche Molecular Systems covering uses of the 5' Nuclease process.

Novato, Calif.-based Biosearch plans to provide dual-labeled 5' Nuclease probes to Roche-licensed CLIA labs providing molecular diagnostic assay. The license provides Biosearch with freedom to operate, with respect to the Roche IP estate, for qPCR processes in the diagnostics research field, the firm said.

The firm will offer the licensed probes as custom analyte-specific reagents, and in vitro diagnostics and oligo components, Biosearch Director of Corporate Development Marc Beal said in a statement.

Financial terms of the agreement were not released.

Filed under

Diagnostics
Roche
LGC
Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.